| Descriptor English: | Proto-Oncogene Proteins c-ret | ||||||
| Descriptor Spanish: |
Proteínas Proto-Oncogénicas c-ret
| ||||||
| Descriptor Portuguese: | Proteínas Proto-Oncogênicas c-ret | ||||||
| Descriptor French: | Protéines proto-oncogènes c-ret | ||||||
| Entry term(s): |
Proto Oncogene Protein Ret Proto Oncogene Protein c ret Proto Oncogene Proteins c ret Proto-Oncogene Protein Ret Proto-Oncogene Protein c-ret Proto-Oncogene Proteins, ret Receptor Tyrosine Kinase RET Ret, Proto-Oncogene Protein c-ret Protein c-ret, Proto-Oncogene Protein c-ret, Proto-Oncogene Proteins ret Proto Oncogene Proteins ret Proto-Oncogene Proteins |
||||||
| Tree number(s): |
D08.811.913.696.620.682.725.400.087 D09.400.430.890.200.188.500 D12.776.395.550.200.188.500 D12.776.476.568.400.087 D12.776.543.131.500 D12.776.543.750.630.217 D12.776.624.664.700.194 |
||||||
| RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D051096 | ||||||
| Scope note: | Receptor protein-tyrosine kinases involved in the signaling of GLIAL CELL-LINE DERIVED NEUROTROPHIC FACTOR ligands. They contain an extracellular cadherin domain and form a receptor complexes with GDNF RECEPTORS. Mutations in ret protein are responsible for HIRSCHSPRUNG DISEASE and MULTIPLE ENDOCRINE NEOPLASIA TYPE 2. |
||||||
| Allowable Qualifiers: |
AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis DE drug effects DF deficiency EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PH physiology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UL ultrastructure UR urine |
||||||
| Registry Number: | EC 2.7.10.1 | ||||||
| Public MeSH Note: | 2006; PROTO-ONCOGENE PROTEIN C-RET was indexed under PROTO-ONCOGENE PROTEINS & RECEPTOR PROTEIN-TYROSINE KINASES 1999-2005 |
||||||
| History Note: | 2006(1999) |
||||||
| DeCS ID: | 50737 | ||||||
| Unique ID: | D051096 | ||||||
| Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
| Date Established: | 2006/01/01 | ||||||
| Date of Entry: | 2005/06/30 | ||||||
| Revision Date: | 2015/12/24 |
-
-
CHEMICALS AND DRUGS
Enzymes and Coenzymes [D08]Enzymes and Coenzymes -
CHEMICALS AND DRUGS
Carbohydrates [D09]Carbohydrates -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins
|
|
Proto-Oncogene Proteins c-ret
- Preferred
| Concept UI |
M0166929 |
| Scope note | Receptor protein-tyrosine kinases involved in the signaling of GLIAL CELL-LINE DERIVED NEUROTROPHIC FACTOR ligands. They contain an extracellular cadherin domain and form a receptor complexes with GDNF RECEPTORS. Mutations in ret protein are responsible for HIRSCHSPRUNG DISEASE and MULTIPLE ENDOCRINE NEOPLASIA TYPE 2. |
| Preferred term | Proto-Oncogene Proteins c-ret |
| Entry term(s) |
Proto Oncogene Protein Ret Proto Oncogene Protein c ret Proto Oncogene Proteins c ret Proto-Oncogene Protein Ret Proto-Oncogene Protein c-ret Proto-Oncogene Proteins, ret Receptor Tyrosine Kinase RET Ret, Proto-Oncogene Protein c-ret Protein c-ret, Proto-Oncogene Protein c-ret, Proto-Oncogene Proteins ret Proto Oncogene Proteins ret Proto-Oncogene Proteins |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey
